| Literature DB >> 3284459 |
A A Patchett1, D Taub, B Weissberger, M E Valiant, H Gadebusch, N A Thornberry, H G Bull.
Abstract
The in vitro antibacterial activities of several halovinylglycine compounds and their L-norvalyl peptide derivatives are presented. The most potent of them, L-norvalyl-L-chlorovinylglycine, displayed good activity against gram-positive organisms, including methicillin-resistant Staphylococcus species. Chlorovinylglycine is an efficient inhibitor of alanine racemase, but the antibacterial activity of L-norvalyl-L-chlorovinylglycine may involve other physiological targets as well.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3284459 PMCID: PMC172167 DOI: 10.1128/AAC.32.3.319
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191